[go: up one dir, main page]

PT100671A - Sal de l-ascorbato de 16-descarboxi-16-hidroxi-metilanfotericina b e processo para a sua preparacao - Google Patents

Sal de l-ascorbato de 16-descarboxi-16-hidroxi-metilanfotericina b e processo para a sua preparacao

Info

Publication number
PT100671A
PT100671A PT10067192A PT10067192A PT100671A PT 100671 A PT100671 A PT 100671A PT 10067192 A PT10067192 A PT 10067192A PT 10067192 A PT10067192 A PT 10067192A PT 100671 A PT100671 A PT 100671A
Authority
PT
Portugal
Prior art keywords
methananothyericin
discarboxy
hydroxy
preparation
ascorbate salt
Prior art date
Application number
PT10067192A
Other languages
English (en)
Other versions
PT100671B (pt
Inventor
Alexander Richard Greenlees
David Timothy Macpherson
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of PT100671A publication Critical patent/PT100671A/pt
Publication of PT100671B publication Critical patent/PT100671B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT10067192A 1991-07-11 1992-07-09 Sal de l-ascorbato de 16-descarboxi-16-hidroxi-metilanfotericina b e processo para a sua preparacao PT100671B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919114949A GB9114949D0 (en) 1991-07-11 1991-07-11 Novel compounds

Publications (2)

Publication Number Publication Date
PT100671A true PT100671A (pt) 1993-10-29
PT100671B PT100671B (pt) 1999-07-30

Family

ID=10698172

Family Applications (1)

Application Number Title Priority Date Filing Date
PT10067192A PT100671B (pt) 1991-07-11 1992-07-09 Sal de l-ascorbato de 16-descarboxi-16-hidroxi-metilanfotericina b e processo para a sua preparacao

Country Status (7)

Country Link
AU (1) AU2230892A (pt)
GB (1) GB9114949D0 (pt)
IE (1) IE922264A1 (pt)
MX (1) MX9204031A (pt)
PT (1) PT100671B (pt)
TW (1) TW199894B (pt)
WO (1) WO1993001203A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7192713B1 (en) 1999-05-18 2007-03-20 President And Fellows Of Harvard College Stabilized compounds having secondary structure motifs
US7981998B2 (en) 2006-12-14 2011-07-19 Aileron Therapeutics, Inc. Bis-sulfhydryl macrocyclization systems
WO2008076904A1 (en) 2006-12-14 2008-06-26 Aileron Therapeutics, Inc. Bis-sulfhydryl macrocyclization systems
CA2677045C (en) 2007-01-31 2016-10-18 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
US7981999B2 (en) 2007-02-23 2011-07-19 Aileron Therapeutics, Inc. Triazole macrocycle systems
KR101623985B1 (ko) 2007-03-28 2016-05-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 스티칭된 폴리펩티드
JP2012515172A (ja) 2009-01-14 2012-07-05 エルロン・セラピューティクス・インコーポレイテッド ペプチド模倣大環状分子
AU2010298338A1 (en) 2009-09-22 2012-04-12 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
KR102104762B1 (ko) 2010-08-13 2020-04-24 에일러론 테라퓨틱스 인코포레이티드 펩티도미메틱 거대고리
CN108929375A (zh) 2011-10-18 2018-12-04 爱勒让治疗公司 拟肽大环化合物
KR102112373B1 (ko) 2012-02-15 2020-05-18 에일러론 테라퓨틱스 인코포레이티드 펩티드모방체 마크로사이클
EP2819688A4 (en) 2012-02-15 2015-10-28 Aileron Therapeutics Inc PEPTIDOMIMETIC MACROCYCLES CROSS-LINKED WITH TRIAZOLE AND THIOETHER
KR20150082307A (ko) 2012-11-01 2015-07-15 에일러론 테라퓨틱스 인코포레이티드 이치환 아미노산 및 이의 제조 및 사용 방법
CN106999541A (zh) 2014-09-24 2017-08-01 艾瑞朗医疗公司 拟肽大环化合物及其用途
SG10201902598VA (en) 2014-09-24 2019-04-29 Aileron Therapeutics Inc Peptidomimetic macrocycles and formulations thereof
MX2017011834A (es) 2015-03-20 2018-04-11 Aileron Therapeutics Inc Macrociclos peptidomimeticos y usos de los mismos.
WO2017004548A1 (en) 2015-07-01 2017-01-05 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
JP2018528217A (ja) 2015-09-10 2018-09-27 エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． Ｍｃｌ−１のモジュレーターとしてのペプチド模倣大環状分子

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8829592D0 (en) * 1988-12-19 1989-02-08 Beecham Group Plc Novel compounds
GB8829593D0 (en) * 1988-12-19 1989-02-08 Beecham Group Plc Novel compounds
EP0431874A1 (en) * 1989-12-08 1991-06-12 Beecham Group p.l.c. Novel compounds
EP0431870A1 (en) * 1989-12-08 1991-06-12 Beecham Group p.l.c. Amphotericin B derivatives

Also Published As

Publication number Publication date
MX9204031A (es) 1993-01-01
IE922264A1 (en) 1993-01-13
WO1993001203A1 (en) 1993-01-21
GB9114949D0 (en) 1991-08-28
TW199894B (pt) 1993-02-11
PT100671B (pt) 1999-07-30
AU2230892A (en) 1993-02-11

Similar Documents

Publication Publication Date Title
PT100671A (pt) Sal de l-ascorbato de 16-descarboxi-16-hidroxi-metilanfotericina b e processo para a sua preparacao
PT100316A (pt) Anticoagulantes e processo para a sua preparacao
BR9103195A (pt) Composto e processo para sua preparacao
BR9408463A (pt) Novos derivados de ginkgolide e processo para sua preparação
PT100915A (pt) Agentes antianginosos de pirazolopirimidinonas e processo para a sua preparacao
BR9206780A (pt) Embalagem solúvel em água e processo para sua produçÃo
PT750907E (pt) Formulacoes de vacinas estaveis para administracao parenterica metodo para a sua utilizacao e processo para a sua preparacao
BR8801373A (pt) Processo para a obtencao de esteraminas quaternarias e sua utilizacao
BR9206523A (pt) Composições termoplásticas e processo para sua preparação
BR9611466A (pt) Vacinas de tumores e processo para a sua preparação
BR9102794A (pt) Processo para a obtencao de tantalo e niobio
BR9202325A (pt) Composto,processo para a sua preparacao,preparado farmaceutico e processo para a sua preparacao
BR9206950A (pt) Composição farmacêutica e processo para sua preparação
BR9300739A (pt) Processo hidrometalurgico para a obtencao de tantalo e niobio
BR9101488A (pt) Preparados de lipossomas,sua utilizacao e processo para a sua producao
BR9200333A (pt) Pistao e processo para sua fabricacao
BR9303456A (pt) Compostos,processo para sua preparacao,medicamentos,processo para sua preparacao e emprego
PT101183A (pt) Antagonistas de ltb4 a base de benzopirano e afins e processo para a sua preparacao
BR8802836A (pt) Processo para a preparacao de imagens
BR9301448A (pt) Composicao e processo para sua preparacao
PT721453E (pt) Processo para a preparacao den-metil-3-(1-metil-4-piperidinil)-1h-indole-5-etanossulfonamida
PT100989A (pt) Vacina contra dermatomicoses e processo para a sua preparacao
BR9200765A (pt) Processo para a preparacao de compostos 4-ciano-pirrol substituidos na posicao 3,brometos e processo para sua preparacao
BR9401483A (pt) Composto e processo para sua preparação
PT862545E (pt) Compostos pesticidas composicoes e processo para a sua preparacao

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19930607

FG3A Patent granted, date of granting

Effective date: 19990415

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20001031